Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andres Cervantes

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 23, 2013
Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinomaJean-Pierre Delord, Josep Tabernero, Rocío García-Carbonero, et al.
Cancer Chemotherapy and Pharmacology|March 4, 2010
Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable, locally advanced gastric and oesophageal-gastric junction adenocarcinomaFernando Rivera, Maica Galán, Josep Tabernero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancerAimery de Gramont, Marc Buyse, Jose Cortinas Abrahantes, et al.
Cancer Medicine|May 7, 2019
Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategyTania Fleitas-Kanonnikoff, Carolina Martinez-Ciarpaglini, Josefina Ayala, et al.
ESMO Open|August 30, 2017
Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribersJosep Tabernero, Malvika Vyas, Rosa Giuliani, et al.
Journal of Clinical Pharmacology|December 18, 2023
Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients with Mixed Solid Tumors (GO30103)Elena Garralda, Do Youn Oh, Antoine Italiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2015
Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithelial TumorsDejan Juric, Rodrigo Dienstmann, Andres Cervantes, et al.
Journal of Global Oncology|February 26, 2019
Early Detection for Colorectal Cancer: ASCO Resource-Stratified GuidelineGilberto Lopes, Mariana C Stern, Sarah Temin, et al.
Clinical Colorectal Cancer|December 12, 2022
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C StudyManish A Shah, Takayuki Yoshino, Niall C Tebbutt, et al.
Journal of Global Oncology|February 26, 2019
Treatment of Patients With Early-Stage Colorectal Cancer: ASCO Resource-Stratified GuidelineAinhoa Costas-Chavarri, Govind Nandakumar, Sarah Temin, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|November 23, 2013
Open-label, multicentre expansion cohort to evaluate imgatuzumab in pre-treated patients with KRAS-mutant advanced colorectal carcinomaJean-Pierre Delord, Josep Tabernero, Rocío García-Carbonero, et al.
Cancer Chemotherapy and Pharmacology|March 4, 2010
Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable, locally advanced gastric and oesophageal-gastric junction adenocarcinomaFernando Rivera, Maica Galán, Josep Tabernero, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancerAimery de Gramont, Marc Buyse, Jose Cortinas Abrahantes, et al.
Cancer Medicine|May 7, 2019
Molecular profile in Paraguayan colorectal cancer patients, towards to a precision medicine strategyTania Fleitas-Kanonnikoff, Carolina Martinez-Ciarpaglini, Josefina Ayala, et al.
ESMO Open|August 30, 2017
Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribersJosep Tabernero, Malvika Vyas, Rosa Giuliani, et al.
Journal of Clinical Pharmacology|December 18, 2023
Pharmacokinetics (PK) of Tiragolumab in First-in-Human Study in Patients with Mixed Solid Tumors (GO30103)Elena Garralda, Do Youn Oh, Antoine Italiano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2015
Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithelial TumorsDejan Juric, Rodrigo Dienstmann, Andres Cervantes, et al.
Journal of Global Oncology|February 26, 2019
Early Detection for Colorectal Cancer: ASCO Resource-Stratified GuidelineGilberto Lopes, Mariana C Stern, Sarah Temin, et al.
Clinical Colorectal Cancer|December 12, 2022
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C StudyManish A Shah, Takayuki Yoshino, Niall C Tebbutt, et al.
Journal of Global Oncology|February 26, 2019
Treatment of Patients With Early-Stage Colorectal Cancer: ASCO Resource-Stratified GuidelineAinhoa Costas-Chavarri, Govind Nandakumar, Sarah Temin, et al.
Pageof 8